RTI uses cookies to offer you the best experience online. By clicking “accept” on this website, you opt in and you agree to the use of cookies. If you would like to know more about how RTI uses cookies and how to manage them please view our Privacy Policy here. You can “opt out” or change your mind by visiting: http://optout.aboutads.info/. Click “accept” to agree.
Postoperative complications do not impact on recurrence and survival after curative resection of gastric cancer
Climent, M., Hidalgo , N., Vidal, Ó., Puig, S., Iglesias, M., Cuatrecasas, M., Ramón, JM., Garcia de Albeniz Martinez, X., Grande, L., & Pera, M. (2016). Postoperative complications do not impact on recurrence and survival after curative resection of gastric cancer. European Journal of Surgical Oncology, 42(1), 132-9. https://doi.org/10.1016/j.ejso.2015.08.163
Background: We assessed the impact of complications on recurrence and survival after curative gastric cancer resection.
Methods: Patients undergoing RO resections between 1990 and 2009 were identified in a prospectively maintained database and were categorized by presence of any complication Clavien-Dindo (CD) >= II, sepsis or infra-abdominal sepsis. Cox regression analyses to relate complications and clinico-pathological variables to time to recurrence (TTR) and overall survival (OS) were performed.
Results: A total of 271 patients were included with a median follow-up of 149.9 months (range 140.1-159.9). Complications CD >= II occurred in 162 (59.8%) patients, sepsis in 66 (22.5%), and intra-abdominal sepsis in 37 (13.6%). Recurrence developed in 88 (32.4%) patients. Independent predictors of short TTR were pTNM stage (1103-LEIC vs. IA-11A) (hazard ratio [HR] = 37.55, 95% confidence interval [CI] 17.57-80.24; p < 0.001), D1 lymphadenectomy (HR = 3.14, 95% CI 1.94-5.07; p < 0.001), and male gender (HR = 1.65, 95% CI 1.06-2.57; p = 0.026). pTNM stage (IIIB-IIIC vs. IA-IIA, HR = 10.28, 95% CI 6.51-16.23; p < 0.001), male gender (HR = 1.64, 95% CI 1.17-2.31; p = 0.005), age (HR = 1.03, 95% CI 1.02-1.05; p < 0.001), and adjuvant therapy (HR = 0.55, 95% CI 0.37-0.83; p = 0.004) were identified as independent predictors of OS.
Conclusions: Evidence provided by this study does not support a negative impact of postoperative complications CD >= II, sepsis, and intra-abdominal sepsis on the oncologic outcome after curative gastric cancer resection. (C) 2015 Elsevier Ltd. All rights reserved.